Daunorubicin Safety Questions, Daunorubicin Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Daunorubicin side effects. Check out Health Surveys and Health Polls. If you have questions about Daunorubicin, you can post them to our Doctors or Ask Patient Community about Daunorubicin.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Daunorubicin
Daunorubicin Safety Reports
Total Daunorubicin reports: 45.Daunorubicin FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 36.
Take Daunorubicin Side Effects Survey or Share Your Daunorubicin Story.
Reported Daunorubicin Side Effects: hypotension, hypoxia, renal failure, disseminated intravascular coagulation, gastrointestinal haemorrhage, blood bilirubin increased, cardiac failure congestive, left ventricular failure, abdominal pain, aeromona infection, blood culture positive.
More About Daunorubicin.
Daunorubicin Side Effects Report #5199641-6
Pharmacist from UNITED STATES reported DAUNORUBICIN problem on Jan 03, 2007. Female patient, 23 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy. DAUNORUBICIN dosage: unknown. During the same period patient was treated with ACYCLOVIR, VORICONAZOLE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5224689-2
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Female patient, weighting 43.30 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, cardio-respiratory arrest, constipation, gallbladder disorder, gallbladder oedema, hypotension, neutropenia, pneumatosis, sepsis. DAUNORUBICIN dosage: 19.3 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, CYTARABINE, BACTRIM. Patient recovered.
Daunorubicin Side Effects Report #5266033-0
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Mar 13, 2007. Female patient, weighting 66.14 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: agitation, anaemia, blood fibrinogen decreased, blood urea increased, clostridium difficile toxin test positive, dehydration, gastrointestinal necrosis, haemodynamic instability, hepatic necrosis. DAUNORUBICIN dosage: 53 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient recovered.
Daunorubicin Side Effects Report #5272643-7
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Male patient, weighting 147.2 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: aeromona infection, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. DAUNORUBICIN dosage: 90 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5273551-8
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Mar 21, 2007. Female patient, weighting 66.14 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, agitation, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood fibrinogen decreased, blood phosphorus increased, blood potassium increased, blood urea increased. DAUNORUBICIN dosage: 53 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, CYTARABINE. Patient recovered.
Daunorubicin Side Effects Report #5273658-5
DAUNORUBICIN problem was reported by a Health Professional from UNITED STATES on Mar 21, 2007. Male patient, 45 years of age, weighting 165.3 lb, was diagnosed with acute myeloid leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: procedural complication, procedural hypertension, sinus bradycardia, torsade de pointes. DAUNORUBICIN dosage: 90 MG/M2 DAILY IV. During the same period patient was treated with ACYCLOVIR, ALLOPURINOL, CEFTAZIDIME, CYTARABINE, FLUCONAZOLE, LEVOFLOXACIN, METRONIDAZOLE. Patient recovered.
Daunorubicin Side Effects Report #5280206-2
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Mar 26, 2007. Male patient, weighting 147.2 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: aeromona infection, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. DAUNORUBICIN dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5283551-X
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 29, 2007. Male patient, weighting 147.2 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: bacterial infection, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. DAUNORUBICIN dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5297834-0
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Apr 13, 2007. Male patient, weighting 147.2 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal candidiasis, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, oral candidiasis, renal failure, respiratory arrest. DAUNORUBICIN dosage: 90 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5297851-0
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, weighting 145.9 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, dizziness, dyspnoea, heart rate increased, hypotension, ventricular dysfunction. DAUNORUBICIN dosage: 318 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5315631-4
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Apr 30, 2007. Male patient, weighting 147.2 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: aeromona infection, candidiasis, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. DAUNORUBICIN dosage: 90 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5327745-3
DAUNORUBICIN problem was reported by a Health Professional from UNITED STATES on Sept 21, 2006. Female patient, weighting 172.0 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive. DAUNORUBICIN dosage: unknown. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5333194-4
Health Professional from UNITED STATES reported DAUNORUBICIN problem on May 21, 2007. Male patient, 45 years of age, weighting 158.5 lb, was diagnosed with acute myeloid leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, fungal infection, multi-organ failure, respiratory failure, zygomycosis. DAUNORUBICIN dosage: 90 MG/M2 Q DAY X 3 DAYS IV DRIP. During the same period patient was treated with CYTARABINE, CIPROFLOXACIN, PENICILLIN VK, AMLODIPINE, ACYCLOVIR, FLUCONAZOLE. Patient died on 05/10/2007.
Daunorubicin Side Effects Report #5355851-6
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Male patient, weighting 147.2 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: aeromona infection, candidiasis, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, left ventricular failure, renal failure, respiratory arrest. DAUNORUBICIN dosage: 90 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5373571-9
Consumer or non-health professional from AUSTRALIA reported DAUNORUBICIN problem on June 26, 2007. Male patient, weighting 147.2 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: aeromona infection, candidiasis, cardiac arrest, disseminated intravascular coagulation, gastrointestinal haemorrhage, hypotension, hypoxia, renal failure. DAUNORUBICIN dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5049843-4
DAUNORUBICIN problem was reported by a Physician from UNITED STATES on June 21, 2006. Female patient, 17 years of age, was diagnosed with acute myeloid leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: haematuria. DAUNORUBICIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE, TIOGUANINE. Patient recovered.
Daunorubicin Side Effects Report #5049863-X
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on June 21, 2006. Male patient, 16 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: metastatic neoplasm, renal mass. DAUNORUBICIN dosage: 38 MILLIGRAM INTRAVENOUS (NOS). During the same period patient was treated with DEXAMETHASONE, CYTARABINE, TIOGUANINE, ETOPOSIDE. Patient died.
Daunorubicin Side Effects Report #5078644-6
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Female patient, weighting 117.7 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atrophic vulvovaginitis, constipation, diverticulum, faecal volume increased, haemorrhoids, neutropenia, rectal haemorrhage. DAUNORUBICIN dosage: 270 MG. During the same period patient was treated with DEXAMETHASONE, ELSPAR, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5081653-4
Physician from CANADA reported DAUNORUBICIN problem on July 17, 2006. Male patient, 73 years of age, weighting 160.9 lb, was diagnosed with acute myeloid leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: subdural haematoma. DAUNORUBICIN dosage: 60MG/M2/IV. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5092190-5
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Male patient, weighting 202.1 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased. DAUNORUBICIN dosage: 424 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5116908-8
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Sept 27, 2006. Male patient, weighting 220.5 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: infection. DAUNORUBICIN dosage: 140 MG. During the same period patient was treated with VINCRISTINE. Patient was hospitalized. Patient died on 12/28/2005.
Daunorubicin Side Effects Report #5120906-8
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2006. Female patient, weighting 154.3 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: bacillus infection, disseminated intravascular coagulation, hypotension, hypoxia, pulmonary haemorrhage, pyrexia. DAUNORUBICIN dosage: 88 MG. During the same period patient was treated with DEXAMETHASONE, CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5130438-9
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Oct 17, 2006. Female patient, weighting 154.3 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: bacillus infection, disseminated intravascular coagulation, hypotension, hypoxia, pulmonary haemorrhage, pyrexia. DAUNORUBICIN dosage: 88 MG. During the same period patient was treated with CYTARABINE, DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5139776-7
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 12, 2006. Female patient, child 7 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bacterial sepsis, caecitis, flatulence, intussusception, nausea, pyrexia, vomiting. DAUNORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE, ASPARAGINASE. Patient recovered.
Daunorubicin Side Effects Report #5146230-5
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Nov 06, 2006. Female patient, weighting 235.2 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardiac failure, dyspnoea, hypotension, hypoxia, sepsis. DAUNORUBICIN dosage: 90 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5173520-2
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2006. Male patient, weighting 154.3 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood albumin decreased, blood bicarbonate decreased, blood fibrinogen decreased, blood ph increased, bronchoscopy abnormal, candidiasis, chest discomfort, chromosome analysis abnormal. DAUNORUBICIN dosage: 330 MG. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5191393-9
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Dec 20, 2006. Female patient, weighting 138.0 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, bacteria tissue specimen identified, blood culture positive, body temperature increased, gastrointestinal necrosis, hypotension, induration, perianal erythema. DAUNORUBICIN dosage: 83.5 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5195925-6
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2006. Female patient, weighting 138.0 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, bacteroides infection, blood bilirubin increased, blood culture positive, body temperature increased, culture tissue specimen positive, erythema, hypotension. DAUNORUBICIN dosage: 83.5 MG. During the same period patient was treated with DEXAMETHASONE, CYTARABINE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5198147-8
Pharmacist from UNITED STATES reported DAUNORUBICIN problem on Dec 28, 2006. Female patient, 60 years of age, was diagnosed with myeloid leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, cardiomyopathy. DAUNORUBICIN dosage: 180 MG ONCE IV. During the same period patient was treated with ASPIRIN, INSULIN, ADVAIR DISKUS, IMDUR, LASIX, LISINOPRIL, PREVACID. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5384973-9
DAUNORUBICIN problem was reported by a Physician from UNITED STATES on June 26, 2007. Male patient, 22 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: malignant melanoma in situ, melanocytic naevus. DAUNORUBICIN dosage: unknown. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5385279-4
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on July 09, 2007. Female patient, weighting 60.85 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood bilirubin increased, jaundice. DAUNORUBICIN dosage: 87 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5390181-8
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, weighting 183.0 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, aspergillosis, blood bilirubin increased, febrile neutropenia, fungaemia, hepatic function abnormal, hepatic steatosis. DAUNORUBICIN dosage: 4 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5392036-1
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on July 18, 2007. Female patient, weighting 60.85 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, jaundice. DAUNORUBICIN dosage: 87 MG. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5393754-1
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2007. Female patient, weighting 60.85 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, jaundice. DAUNORUBICIN dosage: 87 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5400118-0
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on July 27, 2007. Female patient, weighting 183.0 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, acute lymphocytic leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, computerised tomogram abnormal, fungaemia, fungal infection, hepatic function abnormal. DAUNORUBICIN dosage: 4 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5400172-6
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2007. Female patient, weighting 126.1 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, electrocardiogram t wave abnormal, myocardial infarction, myocardial ischaemia, renal failure, sinus tachycardia. DAUNORUBICIN dosage: 72.5 MG. During the same period patient was treated with MYLOTARG, CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5407135-5
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Aug 03, 2007. Male patient, weighting 28.22 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, hypotension, lethargy, pulmonary haemorrhage, shock, vomiting. DAUNORUBICIN dosage: 28 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5409682-9
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Male patient, weighting 28.22 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: lethargy, pulmonary haemorrhage, shock, vomiting. DAUNORUBICIN dosage: unknown. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5419192-0
Consumer or non-health professional from UNITED STATES reported DAUNORUBICIN problem on Aug 15, 2007. Female patient, weighting 126.1 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, electrocardiogram abnormal, myocardial infarction, renal failure, sinus tachycardia. DAUNORUBICIN dosage: 72.5 MG. During the same period patient was treated with CYTARABINE, MYLOTARG. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5447373-9
DAUNORUBICIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2007. Female patient, weighting 169.1 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, dialysis, fungal infection, fungal skin infection, multi-organ failure, oropharyngeal candidiasis, respiratory distress. DAUNORUBICIN dosage: 62 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5447614-8
Consumer or non-health professional from UNITED KINGDOM reported DAUNORUBICIN problem on Aug 21, 2007. Male patient, 74 years of age, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: pneumonia. DAUNORUBICIN dosage: 50 MG/M2 DAILY IV. During the same period patient was treated with CYTARABINE, GEMTUZUMB. Patient died on 07/13/2007.
Daunorubicin Side Effects Report #5456188-7
DAUNORUBICIN problem was reported by a Health Professional from UNITED STATES on Sept 14, 2007. Female patient, weighting 112.9 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, necrotising fasciitis, pseudomonas infection. DAUNORUBICIN dosage: unknown. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5465326-1
Pharmacist from UNITED STATES reported DAUNORUBICIN problem on Sept 20, 2007. Female patient, weighting 112.9 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: abscess, cellulitis, muscle abscess, myositis, necrotising fasciitis, neutropenia, pseudomonas infection. DAUNORUBICIN dosage: 86 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5465330-3
DAUNORUBICIN problem was reported by a Health Professional from UNITED STATES on Sept 20, 2007. Male patient, weighting 138.7 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: colitis, constipation, faecaloma, febrile neutropenia, gastritis, gastrointestinal necrosis, hyponatraemia, inappropriate antidiuretic hormone secretion, large intestine perforation. DAUNORUBICIN dosage: 172 MG. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5468080-2
Health Professional from UNITED STATES reported DAUNORUBICIN problem on Sept 19, 2007. Male patient, weighting 171.1 lb, was treated with DAUNORUBICIN. After drug was administered, patient experienced the following problems/side effects: infection, pyrexia. DAUNORUBICIN dosage: 240 MG. Patient was hospitalized. Patient recovered.